CMS Finalizes New Medicare Drug Price Rules, Expands Rare Disease Protections
WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) released its final guidance for the third cycle of the Medicare Drug Price Negotiation Program on Tuesday, introducing major …
CMS Finalizes New Medicare Drug Price Rules, Expands Rare Disease Protections Read More